Long COVID Trial, Recruiting (NCT06522750)

Long COVID Trial, Recruiting NCT06522750 Sponsor: University of Luxembourg Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT06522750 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 64 years old
You have been diagnosed with Long COVID, meaning you have had COVID-19 symptoms lasting 12 weeks or longer
Your body weight falls within a normal range for your height (BMI between 18.5 and 25)
Your iron levels are on the lower side, specifically a ferritin (iron storage protein) level below 25 ng/ml (confirm with trial site)
You can speak and understand English, German, or French
You are willing and able to sign a consent form agreeing to take part
You agree to having samples (such as blood) collected and used for the study

Who may not be able to join:

You are underweight, or have lost more than 3 kg in the last month or more than 5 kg in the last three months
You have had an eating disorder such as anorexia or bulimia in the past five years
You have a mental health condition that would make it difficult to understand and agree to the study procedures
You have a serious ongoing illness, such as significant kidney disease, or a long-term inflammatory condition other than Long COVID
You are currently taking part in another clinical intervention study
You follow a vegan diet or have done fasting in the last six months
You are pregnant or breastfeeding
You have, or are suspected to have, ME/CFS or early problems with your autonomic nervous system (the system that controls automatic body functions) (confirm with trial site)
You have been diagnosed with inflammatory bowel disease, coeliac disease, or colorectal cancer
You are taking anti-psychotic medication
You have taken antibiotics at any point in the last 12 months
You have recently started taking a new medication
It would not be safe for you to have additional blood taken, for example if your haemoglobin (a measure of red blood cells) is below 10 (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raquel Gomez Bravo, PhD, Rehaklinik du Centre Hospitalier Neuro-Psychiatrique (CHNP), UL

Phone: +3524666446555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06522750

Sponsor: University of Luxembourg

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +3524666446555

More information: https://clinicaltrials.gov/study/NCT06522750

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 64 years old
You have been diagnosed with Long COVID, meaning you have had COVID-19 symptoms lasting 12 weeks or longer
Your body weight falls within a normal range for your height (BMI between 18.5 and 25)
Your iron levels are on the lower side, specifically a ferritin (iron storage protein) level below 25 ng/ml (confirm with trial site)
You can speak and understand English, German, or French
You are willing and able to sign a consent form agreeing to take part
You agree to having samples (such as blood) collected and used for the study

Who may not be able to join:

You are underweight, or have lost more than 3 kg in the last month or more than 5 kg in the last three months
You have had an eating disorder such as anorexia or bulimia in the past five years
You have a mental health condition that would make it difficult to understand and agree to the study procedures
You have a serious ongoing illness, such as significant kidney disease, or a long-term inflammatory condition other than Long COVID
You are currently taking part in another clinical intervention study
You follow a vegan diet or have done fasting in the last six months
You are pregnant or breastfeeding
You have, or are suspected to have, ME/CFS or early problems with your autonomic nervous system (the system that controls automatic body functions) (confirm with trial site)
You have been diagnosed with inflammatory bowel disease, coeliac disease, or colorectal cancer
You are taking anti-psychotic medication
You have taken antibiotics at any point in the last 12 months
You have recently started taking a new medication
It would not be safe for you to have additional blood taken, for example if your haemoglobin (a measure of red blood cells) is below 10 (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Luxembourg

Registry

ClinicalTrials.gov

Start date

19 February 2025

Est. completion

30 June 2025

Where this trial is recruiting

🇱🇺 Luxembourg

Primary endpoints

Nutritional protocol; Fatigue assessment Scale (FAS); Quality of Life (WHOQOL); Functionality (WHODAS 2.0); Anxiety (GAD-7); Depression (PHQ-9); Mood States; Blood preasure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov